166 related articles for article (PubMed ID: 12644474)
21. Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1.
Hanson J; Gorman J; Reese J; Fraizer G
Front Biosci; 2007 Jan; 12():2279-90. PubMed ID: 17127464
[TBL] [Abstract][Full Text] [Related]
22. Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression.
Chakraborty M; Qiu SG; Vasudevan KM; Rangnekar VM
Cancer Res; 2001 Oct; 61(19):7255-63. PubMed ID: 11585763
[TBL] [Abstract][Full Text] [Related]
23. Wilms' tumor gene 1 enhances nutlin-3-induced apoptosis.
Lee SY; Choe YJ; Park JY; Lee SS; Kim YH; Shin SJ; Chung YJ; Kim HS
Oncol Rep; 2014 Jan; 31(1):131-6. PubMed ID: 24190574
[TBL] [Abstract][Full Text] [Related]
24. In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors.
Brieger A; Boehrer S; Schaaf S; Nowak D; Ruthardt M; Kim SZ; Atadja P; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
Biochem Pharmacol; 2004 Jul; 68(1):85-93. PubMed ID: 15183120
[TBL] [Abstract][Full Text] [Related]
25. Despite WT1 binding sites in the promoter region of human and mouse nucleoporin glycoprotein 210, WT1 does not influence expression of GP210.
Olsson M; English MA; Mason J; Licht JD; Ekblom P
J Negat Results Biomed; 2004 Dec; 3():7. PubMed ID: 15613247
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta1 inhibits all-trans retinoic acid-induced apoptosis.
Soucek K; Pacherník J; Kubala L; Vondrácek J; Hofmanová J; Kozubík A
Leuk Res; 2006 May; 30(5):607-23. PubMed ID: 16242776
[TBL] [Abstract][Full Text] [Related]
27. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
28. Radiosensitivity with Par-4 expression in prostate cancer.
Sheikh MS
Cancer Biol Ther; 2002; 1(2):161-2. PubMed ID: 12212614
[No Abstract] [Full Text] [Related]
29. Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas.
Sundaresan A; Claypool K; Mehta K; Lopez-Berestein G; Cabanillas F; Ford RJ
Cell Growth Differ; 1997 Oct; 8(10):1071-82. PubMed ID: 9342185
[TBL] [Abstract][Full Text] [Related]
30. RNAa-mediated overexpression of WT1 induces apoptosis in HepG2 cells.
Qin Q; Lin YW; Zheng XY; Chen H; Mao QQ; Yang K; Huang SJ; Zhao ZY
World J Surg Oncol; 2012 Jan; 10():11. PubMed ID: 22244202
[TBL] [Abstract][Full Text] [Related]
31. In the erythroleukemic cell line HEL Prostate-apoptosis-response-gene-4 (par-4) fails to down-regulate Bcl-2 and to promote apoptosis.
Boehrer S; Brieger A; Schaaf S; Kukoc-Zivojnov N; Nowak D; Ruthardt M; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
Leuk Lymphoma; 2004 Jul; 45(7):1445-51. PubMed ID: 15359646
[TBL] [Abstract][Full Text] [Related]
32. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor (VEGF) is suppressed in WT1-transfected LNCaP cells.
Graham K; Li W; Williams BR; Fraizer G
Gene Expr; 2006; 13(1):1-14. PubMed ID: 16572586
[TBL] [Abstract][Full Text] [Related]
34. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
35. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells.
Kirschner KM; Hagen P; Hussels CS; Ballmaier M; Scholz H; Dame C
FASEB J; 2008 Aug; 22(8):2690-701. PubMed ID: 18424770
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals.
Hu ZB; Yang GS; Li M; Miyamoto N; Minden MD; McCulloch EA
Leukemia; 1995 May; 9(5):789-98. PubMed ID: 7769841
[TBL] [Abstract][Full Text] [Related]
37. Expression and function of prostate-apoptosis-response-gene-4 in lymphatic cells.
Boehrer S; Chow KU; Ruthardt M; Hoelzer D; Mitrou PS; Weidmann E
Leuk Lymphoma; 2002 Sep; 43(9):1737-41. PubMed ID: 12685825
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.
Damon SE; Plymate SR; Carroll JM; Sprenger CC; Dechsukhum C; Ware JL; Roberts CT
Endocrinology; 2001 Jan; 142(1):21-7. PubMed ID: 11145562
[TBL] [Abstract][Full Text] [Related]
39. PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells.
Rah B; ur Rasool R; Nayak D; Yousuf SK; Mukherjee D; Kumar LD; Goswami A
Autophagy; 2015; 11(2):314-31. PubMed ID: 25803782
[TBL] [Abstract][Full Text] [Related]
40. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells.
Spurgers KB; Coombes KR; Meyn RE; Gold DL; Logothetis CJ; Johnson TJ; McDonnell TJ
Oncogene; 2004 Mar; 23(9):1712-23. PubMed ID: 14647426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
